Cost Utility of Competing Strategies to Prevent Endoscopic Transmission of Carbapenem-Resistant Enterobacteriaceae

Overview

Journal Am J Gastroenterol

Specialty Gastroenterology

Date 2015 Nov 4

PMID 26526083

Citations 13

Authors

Christopher V Almario

Folasade P May

Nicholas J Shaheen

Rekha Murthy

Kapil Gupta

Laith H Jamil

Simon K Lo

Brennan M R Spiegel

Affiliations

Soon will be listed here.

Abstract

Objectives: Prior reports have linked patient transmission of carbapenem-resistant Enterobacteriaceae (CRE, or "superbug") to endoscopes used during endoscopic retrograde cholangiopancreatography (ERCP). We performed a decision analysis to measure the cost-effectiveness of four competing strategies for CRE risk management.

Methods: We used decision analysis to calculate the cost-effectiveness of four approaches to reduce the risk of CRE transmission among patients presenting to the hospital for symptomatic common bile duct stones. The strategies included the following: (1) perform ERCP followed by US Food and Drug Administration (FDA)-recommended endoscope reprocessing procedures; (2) perform ERCP followed by "endoscope culture and hold"; (3) perform ERCP followed by ethylene oxide (EtO) sterilization of the endoscope; and (4) stop performing ERCP in lieu of laparoscopic cholecystectomy (LC) with common bile duct exploration (CBDE). Our outcome was incremental cost per quality-adjusted life year (QALY) gained.

Results: In the base-case scenario, ERCP with FDA-recommended endoscope reprocessing was the most cost-effective strategy. Both the ERCP with culture and hold ($4,228,170/QALY) and ERCP with EtO sterilization ($50,572,348/QALY) strategies had unacceptable incremental costs per QALY gained. LC with CBDE was dominated, being both more costly and marginally less effective vs. the alternatives. In sensitivity analysis, ERCP with culture and hold became the most cost-effective approach when the pretest probability of CRE exceeded 24%.

Conclusions: In institutions with a low CRE prevalence, ERCP with FDA-recommended reprocessing is the most cost-effective approach for mitigating CRE transmission risk. Only in settings with an extremely high CRE prevalence did ERCP with culture and hold become cost-effective.

Citing Articles

Endoscopic retrograde cholangiopancreatography, endoscopic papillary balloon dilation, and laparoscopic hepatectomy for intra- and extrahepatic bile duct stones.

Chen Z, Fu H World J Gastrointest Surg. 2025; 17(1):100544.

PMID: 39872759 PMC: 11757201. DOI: 10.4240/wjgs.v17.i1.100544.

A dynamic flow model mimicking duodenoscope reprocessing after bacterial contamination for translational research.

Heuvelmans M, Woudstra W, Wunderink H, Monkelbaan J, van der Mei H Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e153.

PMID: 36483362 PMC: 9726593. DOI: 10.1017/ash.2022.294.

A narrative review on current duodenoscope reprocessing techniques and novel developments.

Heuvelmans M, Wunderink H, van der Mei H, Monkelbaan J Antimicrob Resist Infect Control. 2021; 10(1):171.

PMID: 34949217 PMC: 8697464. DOI: 10.1186/s13756-021-01037-z.

Cost-effectiveness of carbapenem-resistant Enterobacteriaceae (CRE) surveillance in Maryland.

Lin G, Tseng K, Gatalo O, Martinez D, Hinson J, Milstone A Infect Control Hosp Epidemiol. 2021; 43(9):1162-1170.

PMID: 34674791 PMC: 9023597. DOI: 10.1017/ice.2021.361.

Improving the Reprocessing Quality of Flexible Thermolabile Endoscopes: How to Learn from Mistakes.

Casini B, Tuvo B, Marciano E, Del Magro G, Gemignani G, Luchini G Int J Environ Res Public Health. 2021; 18(5).

PMID: 33802350 PMC: 7967619. DOI: 10.3390/ijerph18052482.

References

Neumann P, Cohen J, Weinstein M . Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014; 371(9):796-7. DOI: 10.1056/NEJMp1405158. View

Rutala W, Weber D . Gastrointestinal endoscopes: a need to shift from disinfection to sterilization?. JAMA. 2014; 312(14):1405-6. DOI: 10.1001/jama.2014.12559. View

Epstein L, Hunter J, Arwady M, Tsai V, Stein L, Gribogiannis M . New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014; 312(14):1447-55. PMC: 10877559. DOI: 10.1001/jama.2014.12720. View

Ducomble T, Faucheux S, Helbig U, Kaisers U, Konig B, Knaust A . Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction. J Hosp Infect. 2015; 89(3):179-85. DOI: 10.1016/j.jhin.2014.11.012. View

Smith Z, Oh Y, Saeian K, Edmiston Jr C, Khan A, Massey B . Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines. Gastrointest Endosc. 2015; 81(4):1041-5. DOI: 10.1016/j.gie.2014.11.006. View

Wendorf K, Kay M, Baliga C, Weissman S, Gluck M, Verma P . Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol. 2015; 36(6):634-42. DOI: 10.1017/ice.2015.66. View

Hirth R, Chernew M, Miller E, Fendrick A, Weissert W . Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000; 20(3):332-42. DOI: 10.1177/0272989X0002000310. View

Fowler R, Hill-Popper M, Stasinos J, Petrou C, Sanders G, Garber A . Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care. 2003; 18(3):181-91. DOI: 10.1016/j.jcrc.2003.08.009. View

Doherty D, Falko J, Lefkovitz N, Rogers J, Fromkes J . Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci. 1982; 27(2):169-70. DOI: 10.1007/BF01311712. View

10.

Howard K, Lord S, Speer A, Gibson R, Padbury R, Kearney B . Value of magnetic resonance cholangiopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: a probabilistic cost-effectiveness analysis of diagnostic strategies. Int J Technol Assess Health Care. 2006; 22(1):109-18. DOI: 10.1017/s0266462306050902. View

11.

Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano M, Spirito F . Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007; 102(8):1781-8. DOI: 10.1111/j.1572-0241.2007.01279.x. View

12.

Helling T, Khandelwal A . The challenges of resident training in complex hepatic, pancreatic, and biliary procedures. J Gastrointest Surg. 2007; 12(1):153-8. DOI: 10.1007/s11605-007-0378-6. View

13.

Braithwaite R, Meltzer D, King Jr J, Leslie D, Roberts M . What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?. Med Care. 2008; 46(4):349-56. DOI: 10.1097/MLR.0b013e31815c31a7. View

14.

Anderson D, Shimpi R, McDonald J, Branch M, Kanafani Z, Harger J . Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. Am J Infect Control. 2008; 36(8):592-4. DOI: 10.1016/j.ajic.2007.10.023. View

15.

Keus F, Gooszen H, van Laarhoven C . Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews. Cochrane Database Syst Rev. 2010; (1):CD008318. PMC: 7180153. DOI: 10.1002/14651858.CD008318. View

16.

Wilson E, Gurusamy K, Gluud C, Davidson B . Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg. 2009; 97(2):210-9. DOI: 10.1002/bjs.6872. View

17.

Li V, Yum J, Yeung Y . Optimal timing of elective laparoscopic cholecystectomy after acute cholangitis and subsequent clearance of choledocholithiasis. Am J Surg. 2010; 200(4):483-8. DOI: 10.1016/j.amjsurg.2009.11.010. View

18.

Aumeran C, Poincloux L, Souweine B, Robin F, Laurichesse H, Baud O . Multidrug-resistant Klebsiella pneumoniae outbreak after endoscopic retrograde cholangiopancreatography. Endoscopy. 2010; 42(11):895-9. DOI: 10.1055/s-0030-1255647. View

19.

Muscarella L . Investigation and prevention of infectious outbreaks during endoscopic retrograde cholangiopancreatography. Endoscopy. 2010; 42(11):957-9. DOI: 10.1055/s-0030-1255871. View

20.

Neuner E, Yeh J, Hall G, Sekeres J, Endimiani A, Bonomo R . Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis. 2011; 69(4):357-62. PMC: 3058153. DOI: 10.1016/j.diagmicrobio.2010.10.013. View